Live Webcast Scheduled to Begin at 8:00 a.m. ET Today LEXINGTON, Mass. / Jun 20, 2024 / Business Wire / Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced advancement of... Read More